[MOL] U.S. cancer expert calls for new thinking on clinical trials [01745] Medicine On Line

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[MOL] U.S. cancer expert calls for new thinking on clinical trials

U.S. cancer expert calls for new thinking on clinical trials and
    drug spending
    [09/28/2000; Eureka News Service]

Major changes to the way clinical trials are conducted may be
imperative to avoid unacceptable delays in getting new cancer
treatments on to the market. Moreover, European countries will
need to switch more of their gross domestic product towards healthcare
and be prepared to spend more on pharmaceuticals if people are
to benefit fully from new designer preventives, diagnostics and

These decisions will have to be faced in the very near future
due to the quantum leap in biological technology, according to
Dr Edison Liu, Director of the Division of Clinical Sciences
at the National Cancer Institute in the USA.

He told a news briefing today (Thursday 28 September) at the European
Breast Cancer Conference in Brussels that expression profiling
using DNA microarrays was just one example in his own field of
the new technology that was moving cancer research forward at
an unprecedented pace and had, potentially, an enormous impact
for future prevention, diagnosis, prognosis and treatment.

" It's one of the hottest things in cancer research - the biological
equivalent of a spy satellite that allows you first to see a
continent, then home in on one country, one city, one street
and then a house in that street. The only difference is that
the continent in this case is the cell and we can home in on
groups of genes, single genes, even tiny tags of proteins and
see how they 'live' together, how they interact and what role
they may be playing in a disease.

The full article can be found at:


This is an automatically-generated notice.  If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email